Global fetal bovine serum market was valued at $2.1 billion in 2025 and is growing at a CAGR of 13.3% during the forecast period (2026-2035). Fetal Bovine Serum (FBS) is a common supplement in cell culture, providing essential nutrients, growth factors, and hormones that support cell proliferation and viability. In the context of IVF and fertility treatments, FBS can be used in laboratory processes such as embryo culture and sperm preservation, helping maintain cell health and promoting successful fertilization in vitro. While effective, its use raises ethical concerns and variability issues, leading some laboratories to explore serum-free or humanized alternatives. Overall, FBS plays a supportive role in assisted reproductive technologies by enhancing cell growth and optimizing conditions for embryo development.
Browse the full report description of “Fetal Bovine Serum Market Size, Share & Trends Analysis by Product Type (Charcoal Stripped, Chromatographic, Dialyzed FBS, Stem Cell, and Others) By End-User (Bioproduct & Pharmaceutical Companies, Research Laboratories, Academic Institutes, and Others) By Application (Industrial Research and Research and Scientific Research), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/fetal-bovine-serum-market
Additionally, the rising adoption of advanced bovine reproductive technologies, such as in vitro fertilization (IVF), embryo transfer, and OPU-IVEP techniques, is increasing the demand for high-quality cell culture supplements essential for embryo development and cell viability, thereby supporting market growth. These technologies are being increasingly implemented to enhance reproductive efficiency, improve herd genetics, and optimize dairy productivity. For instance, in September 2024, Indian Immunologicals has introduced 'Shashthi', an IVF media for bovine embryo transfer, developed with the National Dairy Development Board (NDDB). This technology aims to make IVF more affordable for farmers, improving the farmer-centric model of animal husbandry and dairy development. The IVF process, which involves fertilizing an egg in a lab and selecting the healthiest embryos for transfer, is seen as a significant advancement in reproductive technology. In recent years, Ovum Pick Up and In vitro Embryo Production (OPU-IVEP) have emerged as efficient alternatives to traditional embryo production methods, potentially transforming dairying in India.
Key Innovators Driving Fetal Bovine Serum Transformation
The key players in the Fetal Bovine Serum market include Biowest, GE Healthcare Life Sciences, Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.
Market Coverage
Key questions addressed by the report.
Global Fetal Bovine Serum Market Report Segment
By Product Type
By End-User
By Application
Global Fetal Bovine Serum Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/fetal-bovine-serum-market